EUVIMEDEUVIMED entdecken
Crossref

In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard

Yuki Azuma iD, Akiko Asada iD, Misa Tanaka iD, Takahiro Doi iD

Drug Testing and Analysis · 2026

DOI: 10.1002/dta.70042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2026. Verfasst von Yuki Azuma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hygienic Chemistry, Osaka Institute of Public Health, Osaka, Japan. Hauptthemen laut MEDLINE: Lysergic Acid Diethylamide, Hallucinogens. Die Arbeit nennt 30 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysergic acid diethylamide (LSD) analogs represent an emerging class of new psychoactive substances (NPS). These compounds are often rapidly metabolized, making direct detection of the parent compound in biological samples difficult. Therefore, metabolite detection serves as a critical and effective strategy for the confirmation of consumption. However, the metabolic pathways of these analogs remain largely uncharacterized, and synthesized metabolite standards for definitive identification are mostly unavailable. This study investigated the newly emerged LSD analog, (8 R )‐1‐benzoyl‐ N,N ‐diethyl‐6‐methyl‐9,10‐didehydroergoline‐8‐carboxamide (1‐benzoyl‐LSD, 1Bz‐LSD), which features a benzoyl moiety at the N 1 position. The objectives were to characterize its metabolic fate and synthesize a targeted metabolite analyte for the confirmation of consumption. In vitro metabolism of 1Bz‐LSD was examined using human liver microsomes and analyzed through liquid chromatography–quadrupole time‐of‐flight mass spectrometry. The parent compound was rapidly metabolized, yielding 15 metabolites, including LSD. Among these, a deethylated metabolite was detectable over a prolonged period, indicating its potential as a targeted analyte. To confirm its structure, this metabolite was chemically synthesized and identified as 1‐benzoyl‐lysergic acid ethylamide (1Bz‐LAE). The synthesis and identification of 1Bz‐LAE provide a crucial analytical foundation for the investigations of 1Bz‐LSD use, with this metabolite anticipated to function as a valuable marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lysergic Acid DiethylamideHallucinogensHumansMicrosomes, LiverReference StandardsLiquid Chromatography-Mass SpectrometrySubstance Abuse Detection

Stichwörter der Autor:innen

1Bz‐LSDLSD analogin vitro metabolismlysergic acid diethylamidemetabolic pathwaysynthesized metabolite

Substanzen

Lysergic Acid DiethylamideHallucinogens

Autor:innen und Institutionen

  • Division of Hygienic Chemistry, Osaka Institute of Public Health, Osaka, Japan.

ORCID-Profile: Yuki Azuma, Akiko Asada, Misa Tanaka, Takahiro Doi

Förderung

  • JSPS KAKENHI

Zitieren

APA

Azuma, Y., Asada, A., Tanaka, M., & Doi, T. (2026). In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard. Drug Testing and Analysis. https://doi.org/10.1002/dta.70042

Vancouver

Azuma Y, Asada A, Tanaka M, Doi T. In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard. Drug Testing and Analysis. 2026. doi:10.1002/dta.70042

BibTeX
@article{Azuma2026,
  author = {Azuma, Yuki and Asada, Akiko and Tanaka, Misa and Doi, Takahiro},
  title = {In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard},
  journal = {Drug Testing and Analysis},
  year = {2026},
  doi = {10.1002/dta.70042}
}
Kostenlos starten →